Baidu
map

Pain Medicine:初级护理患者的疼痛、慢性疾病、抑郁症与IL-6

2013-05-06 Flower译 医学论坛网

  目前一项发表于《疼痛医学》杂志上的一项研究表明抑郁症可能会增加初级护理患者的疼痛易伤性并可能升高炎症标志物如IL-6的水平。   疼痛、慢性疾病和抑郁症是经常出现在初级护理中非常普遍的问题,炎症标志物水平升高与这三个条件相关,并可能在患者的合并症中起重要作用。该研究旨在探讨疼痛,慢性疾病和炎症标志物白细胞介素(IL)-6的关联是否依赖于初级护理患者的抑郁状况。   该研究受试者为初级护理患

  目前一项发表于《疼痛医学》杂志上的一项研究表明抑郁症可能会增加初级护理患者的疼痛易伤性并可能升高炎症标志物如IL-6的水平。

  疼痛、慢性疾病和抑郁症是经常出现在初级护理中非常普遍的问题,炎症标志物水平升高与这三个条件相关,并可能在患者的合并症中起重要作用。该研究旨在探讨疼痛,慢性疾病和炎症标志物白细胞介素(IL)-6的关联是否依赖于初级护理患者的抑郁状况。

  该研究受试者为初级护理患者(N=106),年龄在40岁以上,该研究对他们的疼痛(36项医学研究成果调查表),慢性疾病发病率(慢性健康状况清单)和抑郁症状(抑郁量表中心)进行了评定。受试者提供血液样品用于血清IL-6测量。

  结果表明,在抑郁症状增加的患者中,IL-6水平与更大的疼痛和慢性疾病合并症相关。无临床明显抑郁症状的患者中,IL-6与疼痛和慢性疾病无关。在调停分析(mediation analysis)中,慢性疾病发病率并不能调节介导素IL-6和疼痛之间的关联,在对慢性疾病发病率调节之后,抑郁症的严重程度和疼痛仍然不相关。

胃旁路术相关的拓展阅读:


Depressive Symptoms, Pain, Chronic Medical Morbidity, and Interleukin-6 among Primary Care Patients
Objective
Pain, chronic medical morbidity, and depression are highly prevalent problems that frequently co-occur in primary care. Elevated levels of inflammatory markers are linked with all three of these conditions and may play an important role in patients’ comorbidities. The current study aimed to examine if the associations among pain, chronic medical morbidity, and the inflammatory marker interleukin (IL)-6 are dependent on depression status in primary care patients.
Setting, Subjects, and Outcome Measures
Primary care patients (N = 106) aged 40 and older were assessed for pain (36-item Medical Outcomes Study Survey Form), chronic medical morbidity (checklist of chronic health conditions), and depressive symptoms (Center for Epidemiologic Studies Depression Scale), and provided a blood sample for the measurement of serum IL-6.
Results
Among patients with elevated depressive symptoms, higher IL-6 levels were associated with both greater pain and greater chronic medical comorbidity. IL-6 was unrelated to pain or chronic medical comorbidity among patients without clinically significant depressive symptoms. In mediation analyses, chronic medical morbidity did not mediate the association between IL-6 and pain, and depression severity and pain remained independently associated after adjustment for chronic medical comorbidity.
Conclusions
Depression may increase primary care patients’ vulnerability to pain and elevated levels of inflammatory markers such as IL-6.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1773446, encodeId=02751e7344645, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Jan 26 22:39:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858570, encodeId=5b6c18585e0f3, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Nov 13 03:39:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077844, encodeId=250620e7844bb, content=<a href='/topic/show?id=e75532239d4' target=_blank style='color:#2F92EE;'>#初级护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32239, encryptionId=e75532239d4, topicName=初级护理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Fri Aug 16 23:39:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273744, encodeId=0e6f12e3744d1, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577402, encodeId=af1115e74028a, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605932, encodeId=dd9516059328c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2014-01-26 kalseyzl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1773446, encodeId=02751e7344645, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Jan 26 22:39:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858570, encodeId=5b6c18585e0f3, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Nov 13 03:39:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077844, encodeId=250620e7844bb, content=<a href='/topic/show?id=e75532239d4' target=_blank style='color:#2F92EE;'>#初级护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32239, encryptionId=e75532239d4, topicName=初级护理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Fri Aug 16 23:39:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273744, encodeId=0e6f12e3744d1, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577402, encodeId=af1115e74028a, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605932, encodeId=dd9516059328c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-11-13 jeanqiuqiu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1773446, encodeId=02751e7344645, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Jan 26 22:39:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858570, encodeId=5b6c18585e0f3, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Nov 13 03:39:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077844, encodeId=250620e7844bb, content=<a href='/topic/show?id=e75532239d4' target=_blank style='color:#2F92EE;'>#初级护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32239, encryptionId=e75532239d4, topicName=初级护理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Fri Aug 16 23:39:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273744, encodeId=0e6f12e3744d1, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577402, encodeId=af1115e74028a, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605932, encodeId=dd9516059328c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1773446, encodeId=02751e7344645, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Jan 26 22:39:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858570, encodeId=5b6c18585e0f3, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Nov 13 03:39:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077844, encodeId=250620e7844bb, content=<a href='/topic/show?id=e75532239d4' target=_blank style='color:#2F92EE;'>#初级护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32239, encryptionId=e75532239d4, topicName=初级护理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Fri Aug 16 23:39:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273744, encodeId=0e6f12e3744d1, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577402, encodeId=af1115e74028a, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605932, encodeId=dd9516059328c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-05-08 kzlchina
  5. [GetPortalCommentsPageByObjectIdResponse(id=1773446, encodeId=02751e7344645, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Jan 26 22:39:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858570, encodeId=5b6c18585e0f3, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Nov 13 03:39:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077844, encodeId=250620e7844bb, content=<a href='/topic/show?id=e75532239d4' target=_blank style='color:#2F92EE;'>#初级护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32239, encryptionId=e75532239d4, topicName=初级护理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Fri Aug 16 23:39:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273744, encodeId=0e6f12e3744d1, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577402, encodeId=af1115e74028a, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605932, encodeId=dd9516059328c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1773446, encodeId=02751e7344645, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Jan 26 22:39:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858570, encodeId=5b6c18585e0f3, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Nov 13 03:39:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077844, encodeId=250620e7844bb, content=<a href='/topic/show?id=e75532239d4' target=_blank style='color:#2F92EE;'>#初级护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32239, encryptionId=e75532239d4, topicName=初级护理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Fri Aug 16 23:39:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273744, encodeId=0e6f12e3744d1, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577402, encodeId=af1115e74028a, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605932, encodeId=dd9516059328c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed May 08 04:39:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

相关资讯

SMJ:音乐治疗可缓解手术患者的疼痛

       肯塔基大学发表的一项新的回顾研究发现,患者在手术前、手术过程中以及手术后接受音乐治疗均有益,它可以减轻康复期间的疼痛感。该研究发表在《Southern Medical Journal》杂志上。        对手术前、术中及术后阶段中应用音乐治疗的患者进行了研究分析,结果发现在所有三个阶段中,行

Nat Commun :疼痛或可实现个体化治疗

  一项关于红斑性肢痛病分子学病因的研究促使耶鲁大学的研究者新开发出了一种疼痛的个体化治疗策略,同时据此他们还可以预测在慢性疼痛患者中,哪些对治疗的反应性较好。   在美国,有超过1/4的人存在慢性疼痛,其中有近40%在现有药物治疗下疼痛未得到有效缓解。在许多常见疾病(如糖尿病神经病变)中,对其导致疼痛的根源尚不十分清楚。   该项发表于《Nature Communications》杂志的新研

J NEUROSCI :大脑疼痛分布图

  科学家已经揭示了我们大脑中精细的疼痛分布图,为我们研究大脑如何使人感到不适,提供了帮助,也有助于我们了解慢性痛的过程。   这个分布图是由伦敦大学学院(University College London,简称UCL)的科学家绘制出的,这也是第一次向人们揭示大脑对于疼痛的精细调控所达到的精度。这项研究发表于《神经科学》杂志,研究中结合应用了功能性核磁共振(fMRI)技术和对于手指的激光刺激

NEJM:功能性磁共振成像或可用于评估疼痛强度

持续性疼痛可通过患者自我报告来测定,仅靠这种方式的测定阻碍诊断和治疗。功能性磁共振成像(fMRI)有望辨别出疼痛的客观指标,但尚未鉴别出针对躯体疼痛的既具有敏感性又具有特异性的脑指标。美国科罗拉多州立大学心理学和神经科学研究所的Wager博士等人对此进行了深入研究,他们发现,使用fMRI来评估健康人中有害高热导致的疼痛强度是可行的。未来的研究需要评估该特征能否预测临床疼痛。研究结果发表于NEJM

JBJS:戒烟可减轻腰背痛患者的疼痛

       许多研究表明吸烟与腰痛、腰椎间盘突出症、患者术后预后不良的风险增加具有关。骨与关节外科杂志(JBJS)2012年12月发表的一项最新研究还发现,患脊柱疾病和相关腰背部疼痛的吸烟者,与在8个月治疗期停止吸烟的脊柱疾病患者相比,不适感更为显著。        几乎所有的成年人都可能在某段时间内因背部疼痛或其

PNAS:研究者揭示机体不同的疼痛机制

近日,来自利兹大学的研究者发现了由神经细胞信号传导引起的疼痛机制,这项研究解释了为什么很多止痛药目前对机体失去作用,以及为未来新的止痛药开发提供了线索。Nikita Gamper教授领导的研究小组调查了持续性痛(如牙痛)和增加的神经敏感性痛(由伤和疾病引起,如痛觉过敏)之间的区别。相关研究成果刊登在了5月14日的国际杂志PNAS上,研究者发现,这两种疼痛都来源于同一种神经,但是确实通过不同机制来产

Baidu
map
Baidu
map
Baidu
map